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Edited by Hans-Dieter KlenkAbstract The enzymatic activity of the SARS coronavirus main
proteinase dimer was characterized by a sensitive, quantitative
assay. The new, ﬂuorogenic substrate, (Ala-Arg-Leu-Gln-
NH)2-Rhodamine, contained a severe acute respiratory syn-
drome coronavirus (SARS CoV) main proteinase consensus
cleavage sequence and Rhodamine 110, one of the most detect-
able compounds known, as the reporter group. The gene for
the enzyme was cloned in the absence of puriﬁcation tags, ex-
pressed in Escherichia coli and the enzyme puriﬁed. Enzyme
activity from the SARS CoV main proteinase dimer could read-
ily be detected at low pM concentrations. The enzyme exhibited
a high Km, and is unusually sensitive to ionic strength and reduc-
ing agents.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Antiviral agents; Fluorogenic substrate; High
throughput screening; Proteinase; Rhodamine; SARS1. Introduction
Severe acute respiratory syndrome (SARS) has been impli-
cated in more than 8000 cases and 900 related deaths since
2003. A coronavirus was identiﬁed as the major cause of SARS
[1,2]. The genome of the SARS coronavirus (SARS CoV), a
positive-stranded RNA virus, has been sequenced [3,4]. The
SARS coronavirus replicase gene contains two overlapping
translation products, polyprotein 1a (450 kDa) and polypro-
tein 1ab (750 kDa). The polyproteins are cleaved by virus-
coded proteinases, one of which is the 3C-like or SARS CoV
main proteinase, a cysteine proteinase with a chymotrypsin-
like fold [5]. Prevention of the proteolytic processing of
coronavirus replicase polyproteins inhibits the production of
infectious virus particles [6], and for this reason the SARS
CoV main proteinase is an attractive target for antiviral
agents. However, before potential inhibitors can be screened,
a sensitive and quantitative assay for enzyme activity must
be developed.
Amino acid derivatives of Rhodamine 110 have been shown
to be extremely sensitive, speciﬁc and selective substrates for
proteinases [7–11]. Bis-substituted substrates are virtuallyAbbreviations: DTT, dithiothreitol; SARS CoV, severe acute respira-
tory syndrome coronavirus
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doi:10.1016/j.febslet.2006.04.004nonﬂuorescent, because the ﬂuorophore is in the lactone state.
Upon cleavage by an endoproteinase of one of the two amide
bonds adjacent to the Rhodamine moiety, the Rhodamine
moiety in the resultant mono-substituted product switches to
the quinone state exhibiting a high degree of conjugation; con-
comitant with this is a massive increase in ﬂuorescence inten-
sity. Rhodamine-based substrates have been used to assay
caspases in vitro [12] and in vivo; trypsin, plasmin and throm-
bin [8]; leucine aminopeptidase and dipeptidyl aminopeptidase
in solution [13] and on the cell surface [14]; cathepsin K in vivo
expressed in CHO cells [15]; elastase [16]; and the adenovirus
proteinase [10,11].
Here we describe the synthesis and puriﬁcation of a highly
sensitive ﬂuorogenic substrate for the SARS CoV main pro-
teinase, (Ala-Arg-Leu-Gln-NH)2-Rhodamine, and the use of
this substrate in the development of a sensitive, and quantita-
tive assay for the enzyme. The amino acid sequence Ala-Arg-
Leu-Gln is similar to sequences recognized by the SARS
CoV main proteinase at cleavage sites in the replicase polypro-
tein [17,18]; cleavage occurs after Gln. We also cloned the gene
for the SARS CoV main proteinase, expressed the gene in
Escherichia coli without puriﬁcation tags, and puriﬁed the en-
zyme. With this substrate, an extremely sensitive, quantitative
assay was developed for measuring SARS CoV main protein-
ase activity. This assay has not only been useful in character-
izing the enzyme but also should be useful in the detection
of inhibitors via high-throughput screening that are potential
antiviral agents.2. Materials and methods
2.1. Materials and methods in Supplementary material
Described in detail in the Supplementary material are: The synthesis
and puriﬁcation of the ﬂuorogenic substrate (Ala-Arg-Leu-Gln-NH)2-
Rhodamine, cloning of the SARS CoV main proteinase, expression
and puriﬁcation of the SARS CoV main proteinase, and conversion
of the primary data in an assay to pmol substrate hydrolyzed per unit
time.
2.2. Assays of the SARS CoV main proteinase
SARS CoV main proteinase in a solution of 25 mM Tris–HCl (pH 8)
was incubated for 5 min at room temperature or at 37 C. Then, (Ala-
Arg-Leu-Gln-NH)2-Rhodamine was added, and the increase with time
in absorbance at 496 nm or in ﬂuorescence at 523 nm was measured.
Continuous ﬂuorescence intensity measurements were made with an
ISS model PC-1 (ISS, Champaign, IL) photon counting spectroﬂuo-
rometer using a 300-W xenon arc lamp and 17 ampere lamp current.
The excitation and emission wavelengths were set to 492 and
523 nm, respectively, with 8 nm excitation and emission slits. Fluores-
cence intensity assays were also performed on a TECAN ULTRA 384
plate reader using Greiner black ﬂat bottom 384-well non-treatedblished by Elsevier B.V. All rights reserved.
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emission wavelength ﬁlters used were 485 and 535 nm, respectively. Be-
fore each experiment, the gain and Z-position were optimized using a
reaction containing the maximal amount of ﬂuorescence that could be
generated in the experiment. The integration time was 40 ls with 10
lamp ﬂashes per measurement. The time-dependent increase in ﬂuores-
cence intensity was monitored, on average, every 9 s depending on the
number of wells being read.3. Results
3.1. Synthesis and puriﬁcation of the ﬂuorogenic substrate
(Ala-Arg-Leu-Gln-NH)2-Rhodamine
(Cbz-Gln-NH)2-Rhodamine was synthesized by incubating
the p-nitrophenyl ester of N-a-CBZ-L-glutamine with Rhoda-
mine110. The product of the reaction was puriﬁed by precipi-
tation with water. After deblocking with HBr in acetic acid,
(Cbz-Leu-Gln-NH)2-Rhodamine was synthesized by activat-
ing the carboxylic acid group of Cbz-L-leucine with 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride and
incubation with (Gln-NH)2-Rhodamine. This process was re-
peated for the addition of Arg and then Ala. The ﬁnal product
(Ala-Arg-Leu-Gln-NH)2-Rhodamine was puriﬁed by ﬂash
chromatography and HPLC.Fig. 1. Chemical structure of the ﬂuorogenic substrate (Ala-Arg-Leu-Gln-N
Rhodamine (B), and Rhodmaine110 (C), with their corresponding normalize
Arg-Leu-Gln-NH)2-Rhodamine does not absorb between 460 and 500 nm,
hydrolysis by the SARS CoV main proteinase, the product, in (B), absorbs
drawn in the quinone state.The structures of the bis-amide substrate (Ala-Arg-Leu-Gln-
NH)2-Rhodamine, its hydrolysis product (Ala-Arg-Leu-Gln-
NH)-Rhodamine, and Rhodamine110 along with their absorp-
tion and emission spectra are shown in Fig. 1. The bis-amide
substrate does not absorb in the visible range as the Rhoda-
mine moiety is in the lactone state. Upon cleavage of (Ala-
Arg-Leu-Gln-NH)2-Rhodamine by the SARS CoV main
proteinase, the mono-amide product (Ala-Arg-Leu-Gln-NH)-
Rhodamine is formed. The mono-substituted product absorbs
around 490 nm, because the Rhodamine-moiety is in the qui-
none state. Ala-Arg-Leu-Gln-NH-Rhodamine exhibits two,
overlapping absorbance peaks with maxima at 469 and
492 nm, whereas Rhodamine 110 has a single absorbance peak
at 496 nm. One interpretation for the origin of the split peak in
the mono-substituted product is: The bis-substituted substrate
is not symmetrical; cleavage of one bond on (Ala-Arg-Leu-
Gln-NH)2-Rhodamine may give rise to a species that absorbs
slightly diﬀerently than if cleavage occurred at the other amide
bond.
3.2. Cloning, expression and puriﬁcation of the SARS CoV main
proteinase
The SARS CoV main proteinase was cloned from viral
mRNA in virus-infected Vero cells via RT-PCR. The bound-H)2-Rhodamine (A), its hydrolysis product (Ala-Arg-Leu-Gln-NH)-
d absorbance spectra. The absorption spectrum in (A) indicates (Ala-
therefore the Rhodamine moiety is drawn in the lactone state. Upon
strongly between 460 and 500 nm, therefore the Rhodamine moiety is
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gated into pET11d plasmid and the resultant plasmid electro-
porated into TOP10 cells for propagation. Finally, the
pET11d-SARS plasmid was transformed into electrocompe-
tent E. coli BL21(DE3) cells. For expression, the BL21(DE3)
cells were grown overnight in autoinduction medium [20]. A
large amount of the enzyme appeared in the supernatant after
centrifugation of the cell lysate, Fig. 2. The soluble proteinase
in the supernatant ﬂowed through a strong cation column con-
nected in series to a strong anion column. The last step in the
puriﬁcation procedure was to apply that ﬂow through to a dif-
ferent strong anion column. The weakly bound enzyme eluted
at a low salt concentration. The cell extract must be very dilute
in order for the enzyme to bind to the POROS 50HQ column.
At this stage, the enzyme was estimated to be greater than 98%
pure. The enzyme is diﬃcult to purify because it has a pI of 6.2
with a net negative charge density of only 3. Its molecular mass
determined by Maldi was 33759; this indicates that N-terminal
methionine was missing.
3.3. Kinetics of hydrolysis of (Ala-Arg-Leu-Gln-NH)2-
Rhodamine by the SARS CoV main proteinase
Is (Ala-Arg-Leu-Gln-NH)2-Rhodamine a substrate for the
SARS CoV main proteinase? Four diﬀerent concentrations
of the SARS CoV main proteinase were incubated withFig. 2. Analysis of the puriﬁcation of the SARS CoV main proteinase
by SDS polyacrylamide gel electrophoresis. The left and right end
lanes contain molecular weight markers, with the numbers shown on
the right indicating the molecular weights of the markers in Da . Lane
2 contains the whole cell extract after cell lysis with lysozyme. Lanes 3
and 4 show the supernatant and pellet, respectively, after centrifuga-
tion at 30000 · g for 30 min. Lane 5 contains the enzyme pool after
passage through strong cation/anion columns in series. Lane 6 shows
the enzyme pool after elution from a second strong anion column. The
SDS–polyacrylamide gel contained 12.5% acrylamide.20 lM (Ala-Arg-Leu-Gln-NH)2-Rhodamine and the increase
in ﬂuorescence monitored as a function of time. The results,
Fig. 3, showed that (Ala-Arg-Leu-Gln-NH)2-Rhodamine was
indeed a substrate for the SARS CoV main proteinase. The in-
crease in ﬂuorescence with time was linear for at least 5 min.
The rates of change in ﬂuorescence, 12, 44, 159, and
231 pM(s)1 increased with increasing enzyme concentrations
125, 250, 500, and 750 nM, respectively. As a control, the
SARS CoV main proteinase was incubated with the ﬂuoro-
genic substrate for the adenovirus proteinase (Leu-Arg-Gly-
Gly-NH)2-Rhodamine [10,11]. No hydrolysis of the compound
was observed (data not shown).
3.4. Optimization of the assay conditions
The eﬀects on enzyme activity of pH, temperature, NaCl
concentration, dithiothreitol (DTT) concentration, and NP-
40 concentration were ascertained in order to optimize the as-
say conditions, Fig. 4. The pH optimum was 8.0, Fig. 4A. The
solid line is the best ﬁt to the experimental data points using a
model system with two ionizable groups with pKa values of 6.8
and 8.7. The optimal temperature for enzyme activity was
about 42 C, Fig. 4B. Enzyme activity increased by only 37%
between 25 and 37 C. There was a dramatic decrease in en-
zyme activity between 42 and 47 C. Enzyme activity was very
sensitive to ionic strength, Fig. 4C. Over 80% of enzyme activ-
ity was inhibited by the presence of 100 mM NaCl. A similar
sensitivity was observed with DTT, Fig. 4D. Over 80% of en-
zyme activity was inhibited in the presence of 2.5 mM DTT.
The nonionic detergent NP-40 also inhibited enzyme activity,
Fig. 4E; about 80% of enzyme activity was inhibited by the
presence of 0.1% (v/v) NP-40.
3.5. Michaelis–Menten parameters
The macroscopic kinetic constants were obtained by incu-
bating 3 lM SARS CoV main proteinase with diﬀerent con-
centrations of (Ala-Arg-Leu-Gln-NH)2-Rhodamine and
measuring the increase in absorbance at 496 nm as a functionTime (sec)
0 50 100 150 200 250 300
(A
la
-
Ar
g-
Le
u
-
G
ln
-N
H)
-R
ho
da
m
in
e 
(nM
)
0
20
40
60
80
100
Fig. 3. Kinetics of hydrolysis of (Ala-Arg-Leu-Gln-NH)2-Rhodamine
by the SARS CoV main proteinase. The SARS CoV main proteinase at
concentrations of () 0.125 lM, (h) 0.25 lM, (,) 0.50 lM, and ()
0.75 lM were incubated with 20 lM (Ala-Arg-Leu-Gln-NH)2-Rhoda-
mine in 1 mL of 25 mM Tris–HCl (pH 8) and the increase in
ﬂuorescence monitored as a function of time. Conversion of arbitrary
ﬂuorescence units to nM substrate hydrolyzed was accomplished by
use of a standard curve.
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Fig. 4. Eﬀect of pH (A), temperature (B), (NaCl) (C), dithiothreitol (D), and NP-40 (E) on the activity of the SARS CoV main proteinase. Assays
were performed at 21 C except those in (B). The reaction mixtures contained 1 lM SARS CoV main proteinase and 20 lM (Ala-Arg-Leu-Gln-
NH)2-Rhodamine in 1 mL 25 mM Tris–HCl (pH 8.0). Enzyme activity was monitored spectroﬂuorometrically. (A) Initial rates of substrate
hydrolysis are plotted as a function of pH in 25 mM buﬀers made at the indicated pHs with sodium citrate, MES, HEPES, TRIS or CHES. The solid
line is the best ﬁt to the experimental data points using a model system with two ionizable groups. (B) Initial rates of substrate hydrolysis are plotted
as a function of temperature in 25 mM Tris–HCl (pH 8) buﬀer. (C)–(F) The eﬀect of increasing concentrations of NaCl, dithiothreitol or NP-40 on
SARS CoV main proteinase activity were measured.
2580 V. Graziano et al. / FEBS Letters 580 (2006) 2577–2583of time. The data are shown in Fig. 5, a plot of the rate of sub-
strate hydrolysis versus the substrate concentration. The rate
of substrate hydrolysis at lower substrate concentrations was
proportional to the concentration of substrate. At higher con-centrations of substrate, the rate of hydrolysis approached sat-
uration. The data could be ﬁt to the classic Michaelis–Menten
hyperbola, the solid line. From this hyperbola, a Km of 306 lM
and a kcat of 0.92 min
1 were calculated.
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Fig. 5. Michaelis–Menten analysis of the interaction of (Ala-Arg-Leu-
Gln-NH)2-Rhodamine with the SARS CoV main proteinase. All
reactions, in 100 lL, contained 3 lM SARS CoV main proteinase, 4%
dimethylsulfoxide, 25 mM Tris–HCl (pH 8.0) and the following
concentrations of substrate: 3.9, 7.8, 15.6, 31.2, 62.5, 125, 250, 500,
1000, or 2000 lM. The rate of hydrolysis was measured by following
the change in absorbance at 496 nm as a function of time. The initial
velocities obtained from the data are plotted versus substrate concen-
tration. The rectangular hyperbola was drawn by ﬁtting the data to the
Michalis–Menten equation from which a Km of 306 lM and a kcat of
0.92 (min)1 were calculated.
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How sensitive is this assay for the SARS CoV main protein-
ase using (Ala-Arg-Leu-Gln-NH)2-Rhodamine as a substrate?
Decreasing concentrations of enzyme, from 325 to 1 nM, were
incubated with 20 lM (Ala-Arg-Leu-Gln-NH)2-Rhodamine
and the increase in ﬂuorescence at 523 nm measured as a func-
tion of time. Linear kinetics were observed (data not shown).
When the rate of substrate hydrolysis was plotted versus the[(SARS 3C)2] (nM)
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Fig. 6. Sensitivity of the SARS CoV main proteinase assay. Diﬀerent
concentrations of the SARS CoV main proteinase dimer, ranging from
325 nM to 1 nM, were incubated with 10 lM (Ala-Arg-Leu-Gln-NH)2-
Rhodamine in 25 mM Tris–HCl (pH 8.0) and the increase in
ﬂuorescence at 523 nm with time measured. The dimer concentration
(SARS 3C)2 was calculated based upon the monomer–dimer equilib-
rium dissociation constant of 6.8 lM (Graziano et al., manuscript in
preparation).SARS CoV main proteinase concentration, the proﬁle was
an exponential function [Graziano et al., in preparation]. How-
ever, when the rate of substrate hydrolysis was plotted versus
the dimer concentration of the SARS CoV main proteinase,
the proﬁle was a straight line through the origin, Fig. 6. The
dimer concentration was calculated using a monomer–dimer
equilibrium dissociation constant of 6.8 lM [Graziano et al.,
in preparation].4. Discussion
Compared to other assays for the SARS CoV main protein-
ase, the assay using (Ala-Arg-Leu-Gln-NH)2-Rhodamine as
the substrate is much more sensitive, by orders of magnitude.
The least sensitive and most laborious assay for the SARS
CoV main proteinase monitors cleavage of peptides by reverse
phase HPLC [18,21,5]. A continuous, chromogenic enzyme as-
say has been developed using p-nitroanilide as the chromo-
phore [22]. However, the extinction coeﬃcient of
paranitroanilide is 8800 M1 cm1, compared to greater than
70000 M1 cm1 for Rhodamine110 [7]. A ﬂuorescence reso-
nance energy transfer (FRET) substrate with Dabcyl and
Edans as the FRET pair and a sequence of 12 amino acid res-
idues containing a SARS CoV main proteinase preferred cleav-
age site has also been used in an assay for the SARS CoV main
proteinase [23]. This assay is not very sensitive, because the
extinction coeﬃcient of Edans at 336 nm is 5438 M1 cm1,
and the quantum yield is only 0.36 [24]. The quantum yield
for Rhodamine110 is greater than 0.90 [7]. Furthermore, a sub-
strate containing FRET pairs incorporated into a peptide of 12
amino acids is very expensive.
The amino acid sequence (Ala-Arg-Leu-Gln) was chosen
for the Rhodamine-based substrate for several reasons. Stud-
ies of the 11 conserved interdomain junctions cleaved on the
viral polyprotein by the SARS CoV main proteinase revealed
that the substrate speciﬁcity is determined by the amino acids
in the P2, P1 and P1 0 positions [17,18]. All 11 cleavage sites
in the SARS coronavirus polyprotein have a conserved
Gln in the P1 position, 8 have a Leu in the P2 position,
and 9 have either Ala or Ser in the P1 0 position. Peptides
with other amino acids in the P2, P1, and P1 0 positions are
poorer substrates or are not cleaved at all. More recently,
studies of 34 peptide substrates reveal that residues at posi-
tions P4 and P3 are also critical for substrate recognition
and binding [25]. The P3 position likes a positively charged
amino acid. The P4 position likes amino acids with high
b-sheet tendency, such as Val or Thr.
Bis-substituted derivatives of Rhodamine110 are sensitive,
speciﬁc and selective substrates for proteinases, a combina-
tion exhibited by no other class of synthetic substrates. They
are sensitive substrates, because they are nonﬂuorescent, but,
upon cleavage of a single amide bond become highly ﬂuores-
cent, exhibiting large molar absorbance coeﬃcients and
quantum yields over a wide pH range, from pH 3 to 12. They
are particularly useful in the neutral to basic pH range where
the output from a xenon lamp is relatively high and where
interference from most biological compounds is low. They
are speciﬁc substrates whose speciﬁcity is further enhanced
upon cleavage of a single amide bond, because the ﬂuoro-
phore undergoes conversion from the lactone to the quinone
state. This process is accompanied by an increase in the de-
2582 V. Graziano et al. / FEBS Letters 580 (2006) 2577–2583gree of conjugation and hence stability which leads to an
enhancement of the reactivity of the susceptible bonds in
the substrate. They are selective substrates because their
structure mimics the amino acid sequence in the reactive site
of a proteinase’s natural substrate.
The bifunctionality of the bis-substituted Rhodamine-based
substrates does not complicate the interpretation of kinetic
data, provided that no more than 5% of the substrate is hydro-
lyzed during an assay. Indeed, bi-functionality may even con-
fer certain advantages. The eﬀective concentration of
susceptible amide bonds is twice the substrate concentration.
Also, the presence of two peptides per Rhodamine110 moiety
may enhance the solubility of the substrate.
How do the properties of mono-substituted Rhodamine and
Rhodamine110 compare to those of the highly used reporting
group 7-amino-4-methylcoumarin? The relative detectabilites
of diﬀerent ﬂuorophores under enzyme assay conditions [7]
can be compared using a molar ﬂuorescence coeﬃcient, whose
dimensions are relative ﬂuorescence units per molar concentra-
tion of ﬂuorophore. The molar ﬂuorescence coeﬃcient of
mono-substituted Rhodamine is 4.5-fold greater than that
for 7-amino-4-methylcoumarin. This diﬀerence is, in part, the
result of the absorption of mono-substituted Rhodamine being
5-fold greater than that of 7-amino-4-methylcoumarin, the
quantum yield for mono-substituted Rhodamine being 0.5-
fold that of 7-amino-4-methylcoumarin, the eﬃciency of the
excitation optics at 492 nm being 3-fold greater than that at
380 nm, and the eﬃciency of the emission optics at 523 being
0.62-fold that at 460 nm. The molar ﬂuorescence coeﬃcient
of Rhodamine110 is 45-fold greater than that for 7-amino-4-
methylcoumarin.
The Michaelis constant, Km, of 306 lM is unusually high for
a Rhodamine-based substrate. The kcat was 0.92 min
1. How-
ever, this is probably a reﬂection of the enzyme and not the
substrate. Fluorescence resonance energy transfer (FRET)
substrates have been used to measure the enzymatic activity
of the SARS CoV main proteinase. They have yielded Km val-
ues ranging from 404 to 16 lM [23,26–30]. With EDANS-
VNSTLQSGLRK-Dabs, the Km is 404 lM and the kcat is
1.08 min1 [26], quite similar to the numbers we obtained with
the Rhodamine-based substrate. With Abz-TSAVLQSGFRK-
DNP, the Km is 253 lM and the kcat is 0.3 min
1 [29]. The
FRET substrates not only contain the P1 and P1 0 amino acids,
but, they also contain 5 amino acids before and after the cleav-
age site; thus, those substrates should occupy almost all of the
speciﬁcity pockets in the enzyme. Although the Rhodamine-
based substrates do not contain amino acids on the C-terminal
side of the cleavage site and hence do not occupy those
speciﬁcity pockets, this apparently does not matter in terms
of kinetic constants that can be obtained.
The experiments to optimize assay conditions revealed sev-
eral interesting characteristics of the SARS CoV main pro-
teinase. The data points in the experiment in Fig. 4A where
enzyme activity was plotted as a function of pH could best
be ﬁt to a model system with two ionizable groups, pKa values
of 6.8 and 8.7, and an optimal pH of 8. With the archetype
cysteine proteinase papain, kcat/Km values as a function of
pH exhibit a bell-shaped curve with a pH optimum of 6–7
and pKa values of 3.3 for Cys25, and 8.3 for His159 [31].
On the other hand, the structure of the rhinovirus 2A protein-
ase [32] which is structurally similar to the SARS CoV main
proteinase [5,33] also exhibits a bell-shaped kcat/Km versuspH curve but with an optimum pH of 8 and pKa values of
7.34 for Cys106 and 8.54 for His28 [34]. The activity of the
SARS CoV main proteinase was unusually insensitive to tem-
perature. The optimal temperature was about 42 C, but en-
zyme activity only increased by 37% between 25 and 37 C.
In contrast, the adenovirus proteinase which is also a cysteine
proteinase has a temperature optimum of 45 C, and enzyme
activity increases 4-fold between 25 and 37 C [11]. The SARS
CoV main proteinase activity was very sensitive to ionic
strength in that 80% of enzyme activity is lost by the presence
of 100 mM NaCl. In contrast, the activity of the adenovirus
proteinase in the absence of a nucleic acid cofactor is very
insensitive to ionic strength. It has been postulated that there
may be a salt bridge between Glu166 in the SARS CoV main
proteinase and the P3 amino acid in the substrate if it is pos-
itively charged [25]. Perhaps this is why enzyme activity is so
sensitive to ionic strength.
The assay described here for the SARS CoV main proteinase
is extremely sensitive. To show exactly how sensitive the assay
is, one must know the concentration of active enzyme. The
crystal structure of the 3C-like proteinase from transmissible
gastroenteritis virus [33] and from human coronavirus [5] is
that of a dimer. And evidence has been published that indi-
cates the dimer is the functional form of the enzyme
[18,23,35]. We have characterized the monomer–dimer equilib-
rium of the SARS CoV main proteinase by small-angle X-ray
scattering, chemical cross linking, and enzyme kinetics and
determined that the equilibrium dissociation constant is
6.8 lM (Graziano et al., manuscript in preparation). This
number was used to calculate the dimer concentration in
Fig. 6. The substrate concentration in the experiment in
Fig. 6 was 20 lM; since the Km was 306 lM, the results of this
experiment imply that if one were to assay the SARS CoV
main proteinase at a substrate concentration equal to the
Km, enzyme activity from as low a concentration as 66 pM
SARS CoV main proteinase dimer could be quantitatively
observed.
The search for inhibitors of the SARS CoV main protein-
ase that may act as antiviral agents should be facilitated by
use of this assay. The assay is particularly adaptable to high
throughput screening. Very small microwells can be used to
conserve enzyme, substrate and potential inhibitors. The as-
say is versatile in that substrate hydrolysis can be measured
not only by ﬂuorescence at 523 nm but also by absorbance
at 496 nm. Kinetic analysis of compounds that inhibit the
SARS CoV main proteinase can be designed to reveal
whether a compound inhibits substrate binding or dimer for-
mation. Finally, since some Rhodamine-based substrates
have been shown to enter cells, (Ala-Arg-Leu-Gln-NH)2-
Rhodamine may be useful as a reporter for SARS coronavi-
rus-infected cells.
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